首页 文献索引 SCI期刊 AI助手
登录 注册
首页 正文

Alimentary pharmacology & therapeutics. 2025 Apr 4. doi: 10.1111/apt.70126 Q16.62024

Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-Associated Steatotic Liver Disease Related HCC Versus Other Aetiologies-Authors' Reply

来信:比较PD-1抑制剂辅助治疗代谢 dysfunction-associated 脂质性肝病相关 hepatocellular carcinoma 与其它病因的疗效——作者回信 翻译改进

Isabella Lurje  1  2, Deniz Uluk  2  3, Frank Tacke  1, Georg Lurje  2  3

作者单位 +展开

作者单位

  • 1 Department of Gastroenterology and Hepatology, Campus Charité Mitte and Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • 2 Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • 3 Department of Surgery, Campus Charité Mitte, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • DOI: 10.1111/apt.70126 PMID: 40184043

    摘要 中英对照阅读

    Copyright © Alimentary pharmacology & therapeutics. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Alimentary pharmacology & therapeutics

    缩写:ALIMENT PHARM THER

    ISSN:0269-2813

    e-ISSN:1365-2036

    IF/分区:6.6/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Letter: Comparing the Efficacy of Adjuvant PD-1 Inhibitor After Curative Resection for Metabolic Dysfunction-Associated Steatotic Liver Disease Related HCC Versus Other Aetiologies-Authors' Reply